Discover
CASH
Pathward Financial, Inc.
89.69
2 x 63.88
2 x 113.03
bid
ask
+
2.63
3.02%
2 @ 04:00 PM
89.69 +0.00 (0.00%)
| Ytd | 26.32% | |
| 1y | 9.97% |
86.69
day range
89.74
65.87
52 week range
101.26
| Open | 86.94 | Prev Close | 87.06 | Low | 86.69 | High | 89.74 | Mkt Cap | 1.89B |
| Vol | 405.75K | Avg Vol | 216.60K | EPS | 8.41 | P/E | 10.66 | Forward P/E | 9.28 |
| Beta | 0.62 | Short Ratio | 11.29 | Inst. Own | 102.13% | Dividend | 0.20 | Div Yield | 0.23 |
| Ex Div Date | 06-11 | Earning | 04-22 | 50-d Avg | 84.37 | 200-d Avg | 81.29 | 1yr Est | 107.50 |
CASH News
businesswire.com
U.S. News & World Report Names Pathward a 2026-2027 Best Company to Work For
SIOUX FALLS, S.D.--(BUSINESS WIRE)--U.S. News & World Report Named Pathward a 2026-2027 Best Company
prnewswire.com
OLD REPUBLIC ANNOUNCES RESULTS OF THE SPECIAL MEETING OF MEMBERS OF EVERETT CASH MUTUAL INSURANCE CO
CHICAGO, June 30, 2026 /PRNewswire/ -- Old Republic International Corporation (NYSE: ORI) – today an
prnewswire.com
THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHA
Theravance Biopharma shareholders to receive $17.00 per share in cash, representing an equity value
businesswire.com
TESTtest Testing Statements by TEST That Reflect Expectations
TEST CITY, Calif.--(BUSINESS WIRE)---- $cash #hash--This press release contains statements and typos